The Role of Non-Pharmaceutical Fentanyl-Contaminated Counterfeit Oxycodone in Increasing Opioid Overdoses: A Commentary Review
Conclusion: Clinicians should counsel patients at risk for opioid misuse on the risks of counterfeit oxycodone.Prim Care Companion CNS Disord 2023;25(6):22nr03433.Author affiliations are listed at the end of this article.PMID:37976226 | DOI:10.4088/PCC.22nr03433
Source: Primary Care - Category: Primary Care Authors: Grace E Hartmann Roopa Sethi Source Type: research
More News: Databases & Libraries | Drugs & Pharmacology | Fentanyl | Overdose | Oxycodone | OxyContin | Primary Care | Study | USA Health